Clinical trial
Minocycline in Patients With Huntington's Disease
NCT00029874 · FDA Office of Orphan Products Development, U.S. Fed · Completed
Key facts
| NCT number | NCT00029874 |
|---|---|
| Title | Minocycline in Patients With Huntington's Disease |
| Official title | Minocycline Dosing and Safety in Huntington's Disease |
| Lead sponsor | FDA Office of Orphan Products Development, U.S. Fed |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Huntington's Disease |
| Intervention type | Drug |
| Interventions | Minocycline |
| Enrollment | 63 |
| Start date | Sep 1, 2001 |
| Completion | Aug 1, 2003 |
| First posted | Jan 25, 2002 |
| Last update posted | Mar 25, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: